Afrocab Treatment Access Partnership

AFROCAB NAIROBI 2014 MEETING AfroCAB is a network for community HIV treatment advocates across  Africa.

AfroCAB’s main objectives are to:

  • Build leadership and advocacy capacity in Africa among PLHIV and advocates on drug development and access issues, particularly around access to essential medicines, including originator and quality generic antiretroviral formulations.
  • Create a platform for engagement with originator and generic pharmaceutical industry as well as other relevant stakeholders.
  • Promote and strengthen Africa-focused research through patient and community participation in protocol design, ethics committees, field activities and documentation of findings, including drug resistance monitoring and its impact on communities.
  • Support development of country-specific strategies and action plans.
  • Facilitate sharing and learning among African PLHIV leaders and advocates around access to ART and the wider treatment issues.
  • Promote evidence-based drug safety practices and support the development of updated treatment guidelines

AfroCAB membership is from 13 African countries. AfroCAB works in partnership with TAC in South Africa.


The establishment of the Community Advisory Board (CAB) serves to foster engagement with civil society groups to co-develop product adoption and roll-out strategies and to improve understanding of and demand for new medicines. The role of the CAB is to provide strategic direction and leadership to strengthen community engagement in project implementation, to foster demand generation, and to ensure that the project as a whole supports and complements the activities of the global HIV treatment community. See activities here.

Published: July 27, 2010
Last edited: July 28, 2021